StockData

Ranpak vs Rayonier Advanced Materials

PACK and RYAM side by side, both in paper and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How PACK and RYAM compare

Rayonier Advanced Materials is the larger company, worth 1.2 times as much as Ranpak ($374M against $305M).

Ranpak grew revenue faster over the last twelve months (8.3% versus 1.9% for Rayonier Advanced Materials).

Ranpak keeps more of each dollar of sales as profit, with a net margin of −8.3% compared with −24.4% at Rayonier Advanced Materials.

Ranpak scores higher on the StockData Score (6 against 5 for Rayonier Advanced Materials), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricPACKRYAM
Size and price
Market cap$305M$374M
Share price$3.55$5.53
Change, 1 year−29.0%−11.5%
Change, 5 years−91.6%−6.7%
Beta (5Y)2.021.21
Employees8002,325
StockData Score
Total score6 (better)5
Valuation score33
Growth score11
Performance score00
Health score2 (better)1
Dividend score00
Valuation
P/S0.7×0.3× (better)
P/B0.6×–
EV/EBITDA14.9×–
Fair value$4.17$13.35
Margin of safety14.9%58.6% (better)
Growth
Revenue growth (TTM)8.3% (better)1.9%
Revenue growth, 5Y average5.8% (better)1.8%
Profitability
Gross margin33.8% (better)4.5%
Operating margin−1.7% (better)−17.2%
Net margin−8.3% (better)−24.4%
Return on equity−6.6% (better)−241%
Return on invested capital−0.64% (better)−23.5%
Financial health
Debt / equity0.79–
Net debt / EBITDA8.01–
Interest coverage−0.2× (better)−2.6×
Current ratio1.79 (better)1.28
Altman Z-score0.48 (better)0.28
Piotroski F-score4 (better)3
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions89.9%79.8%
Held by insiders45.3%10.0%
Insider net buying, 12 months−$18.7K−$17.6K (better)
Short interest, % of float4.2%7.4%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.